A dose-escalating study of the safety and pharmacokinetics of GSK679586A in healthy volunteers and mild asthmatics.

Trial Profile

A dose-escalating study of the safety and pharmacokinetics of GSK679586A in healthy volunteers and mild asthmatics.

Completed
Phase of Trial: Phase I

Latest Information Update: 23 May 2012

At a glance

  • Drugs GSK 679586A (Primary)
  • Indications Asthma
  • Focus Adverse reactions
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 18 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov
    • 05 Jan 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top